Atlas Trials

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Clinical trial NCT00006029 · COMPLETED

Trial details

NCT number
NCT00006029
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2000-07-01
Primary completion
2007-02-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.